SCHEMBL6380771

SCHEMBL6380771

[CH2]CCOCCCOC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20314559 0.87 CYP4F2 (0.35) CYP4F2CYP4A11
SCHEMBL20314556 0.87 CYP4F2 (0.35) CYP4F2CYP4A11
SCHEMBL20314555 0.87 CYP4F2 (0.35) CYP4F2CYP4A11
SCHEMBL6381802 0.85
SCHEMBL20436939 0.82 CYP4F2 (0.33) CYP4F2CYP4A11
SCHEMBL105311 0.79
SCHEMBL235300 0.79
SCHEMBL3683039 0.79 TSHR (0.30)
SCHEMBL3673825 0.79 TSHR (0.30)
SCHEMBL10717480 0.79 MAPK1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050085516-A1 2-W-diaminocarboxylic acid compounds BASF AKTIENGESELLSCHAFT (DE) 2005-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085516-A1 2-W-diaminocarboxylic acid compounds DDT, ANTXR2, MTX2 CYP4F2 467/4885CYP4A11 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.